The top Republican on an influential Senate committee yesterday asked the nation’s two largest contract pharmacy companies for detailed information [...] …
Category: News Alert
Novo Nordisk will lift restrictions in Arkansas on 340B providers’ contract pharmacy arrangements and Arkansas will suspend enforcement against the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Japanese pharmaceutical giant Takeda last Friday became the 29th drugmaker to place conditions on 340B pricing in the contract pharmacy [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
In the wake of a high-profile federal court ruling casting doubt on the definition of eligible “patient” in the 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The top Republican on an influential Senate committee today asked two community health centers to submit detailed financial information on [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Medicare Part B will continue to pay hospitals for 340B drugs at the rate of average sales price (ASP) plus [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Medicare issued a final rule today to implement a $9 billion lump sum payment to 340B hospitals and to cut [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Generic and biosimilar drugmaker Sandoz today became the 28th pharmaceutical company to place conditions on 340B pricing involving drug shipments [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
GlaxoSmithKline (GSK) today became the fifth drug manufacturer to loosen or end its 340B contract pharmacy restrictions in Arkansas and [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A final rule to implement the 340B administrative dispute resolution (ADR) process arrived this week at the last stage of [...] …